OpenAlex
PricingAboutJobs
Log inGet started
Work

Neoantigen quality, not quantity

HTML PDF

Year: 2019
Type: article
Abstract: Prioritizing expressed clonal neoantigens in genes required for cancer cell survival may reduce the likelihood of resistance to neoantigen therapies.
Source: Science Translational Medicine
DOI: 10.1126/scitranslmed.aax7918
Authors: Nicholas McGranahan, Charles Swanton
Institutions: Cancer Research UK, University College London, The Francis Crick Institute
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: neoantigens, cancer immunotherapy resistance, expressed genes, tumor cell survival, neoantigen prioritization
SDG: Good health and well-being

Open Access status: green

Funders: Wellcome Trust, Francis Crick Institute, Cancer Research UK, National Institute for Health and Care Research, European Commission, Rosetrees Trust, Novo Nordisk Fonden, Medical Research Council
Awards: G101352877, G154923120, G182428912, G1872847433, G1996051669, G2646115653, G2721152307, G279952926, G3486387481, G3972042097, G4598959000, G4653762689, G5298051555, G563205138, G6774517903, G6923477830, G7294650718, G8003459845, Mapping the constraints and selection pressures of lung cancer evolution
OpenAlex ID: W2969503240
FWCI: 7.877
Cites: 10
Cited by: 147
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security